A detailed history of Scott Capital Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Scott Capital Advisors, LLC holds 721 shares of LLY stock, worth $650,853. This represents 0.2% of its overall portfolio holdings.

Number of Shares
721
Previous 651 10.75%
Holding current value
$650,853
Previous $506,000 28.85%
% of portfolio
0.2%
Previous 0.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$724.87 - $909.04 $50,740 - $63,632
70 Added 10.75%
721 $652,000
Q1 2024

Apr 17, 2024

BUY
$592.2 - $792.28 $89,422 - $119,634
151 Added 30.2%
651 $506,000
Q4 2023

Jan 10, 2024

BUY
$525.19 - $619.13 $34,137 - $40,243
65 Added 14.94%
500 $291,000
Q3 2023

Oct 19, 2023

BUY
$434.7 - $599.3 $189,094 - $260,695
435 New
435 $233,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $858B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Scott Capital Advisors, LLC Portfolio

Follow Scott Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scott Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scott Capital Advisors, LLC with notifications on news.